Literature DB >> 35975251

EPIGENETIC FACTORS OF SERUM URIC ACID LEVEL AND RELATED GENE POLYMORPHISMS IN SHENYANG, CHINA.

L Wang1, X Chen1, L Han2, B Jin3, W Han2, J Jia4, X Bai2, Z Teng5.   

Abstract

Background: The purpose of this study was to explore the influencing factors of serum uric acid (SUA) level and related gene polymorphisms in the healthy population.
Methods: A total of 346 healthy individuals screened from different areas in Shenyang City and 195 patients with high SUA levels were included.
Results: The levels of TC (total cholesterol), HDL-C (high-density lipoprotein cholesterol), LDL-C (low-density lipoprotein cholesterol), TG (triglycerides), GLU (blood glucose) ALT (alanine aminotransferase), TBA (total bile acid), TBIL (total bilirubin), CR (creatinine) and CYSC (Cystatin C) were statistically different between the healthy and hyperuricemia population (P<0.05). However, there was no statistical difference in the UA level between the two groups (P>0.05). After adjusting for UA, TC, HDL-C, LDL-C, GLU, TBIL and CYSC, the additive and recessive models of rs2231142 were statistically significant in females (P<0.05). For males, haplotypes of A-C-A-A-G-G, A-C-G-C-G-G and A-T-G-A-A-G had significant difference between the healthy and hyperuricemia population (P<0.05). For females, the haplotypes of A-C-G-C-G-G and A-T-A-C-A-T had significant differences (P<0.05).
Conclusion: The distributions of SLC2A9 (solute carrier family 2 and facilitated glucose transporter member 9), ABCG2 (ATP-binding cassette G2), GCKR (glucokinase regulatory protein), KCNQ1, IGFIR (Insulin-like growth factor-I receptor) and VEGFR (Vascular Endothelial Growth Factor Receptor) were balanced in the population in Shenyang City. The haplotypes of A-C-A-A-G-G, A-C-G-C-G-G and A-T-G-A-A-G were the influencing factors of high SUA in the population in Shenyang City. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  gene polymorphisms; hypemricemic population; serum uric acid

Year:  2022        PMID: 35975251      PMCID: PMC9365425          DOI: 10.4183/aeb.2022.1

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  39 in total

Review 1.  Gout.

Authors:  Fernando Perez-Ruiz; Nicola Dalbeth
Journal:  Rheum Dis Clin North Am       Date:  2019-11       Impact factor: 2.670

2.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

3.  Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish.

Authors:  Patrick F McArdle; Afshin Parsa; Yen-Pei C Chang; Matthew R Weir; Jeffery R O'Connell; Braxton D Mitchell; Alan R Shuldiner
Journal:  Arthritis Rheum       Date:  2008-09

4.  Decreased extra-renal urate excretion is a common cause of hyperuricemia.

Authors:  Kimiyoshi Ichida; Hirotaka Matsuo; Tappei Takada; Akiyoshi Nakayama; Keizo Murakami; Toru Shimizu; Yoshihide Yamanashi; Hiroshi Kasuga; Hiroshi Nakashima; Takahiro Nakamura; Yuzo Takada; Yusuke Kawamura; Hiroki Inoue; Chisa Okada; Yoshitaka Utsumi; Yuki Ikebuchi; Kousei Ito; Makiko Nakamura; Yoshihiko Shinohara; Makoto Hosoyamada; Yutaka Sakurai; Nariyoshi Shinomiya; Tatsuo Hosoya; Hiroshi Suzuki
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

5.  The role of KCNQ1 in mouse and human gastrointestinal cancers.

Authors:  B L N Than; J A C M Goos; A L Sarver; M G O'Sullivan; A Rod; T K Starr; R J A Fijneman; G A Meijer; L Zhao; Y Zhang; D A Largaespada; P M Scott; R T Cormier
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

6.  Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.

Authors:  Raffaele Ferrari; Mina Ryten; Roberto Simone; Daniah Trabzuni; Nayia Nicolaou; Naiya Nicolaou; Geshanthi Hondhamuni; Adaikalavan Ramasamy; Jana Vandrovcova; Michael E Weale; Andrew J Lees; Parastoo Momeni; John Hardy; Rohan de Silva
Journal:  Neurobiol Aging       Date:  2014-01-13       Impact factor: 4.673

7.  An Anthropometric Risk Index Based on Combining Height, Weight, Waist, and Hip Measurements.

Authors:  Nir Y Krakauer; Jesse C Krakauer
Journal:  J Obes       Date:  2016-10-18

8.  Gout: will the "King of Diseases" be the first rheumatic disease to be cured?

Authors:  Jasvinder A Singh
Journal:  BMC Med       Date:  2016-11-11       Impact factor: 8.775

9.  GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Authors:  Akiyoshi Nakayama; Hirofumi Nakaoka; Ken Yamamoto; Masayuki Sakiyama; Amara Shaukat; Yu Toyoda; Yukinori Okada; Yoichiro Kamatani; Takahiro Nakamura; Tappei Takada; Katsuhisa Inoue; Tomoya Yasujima; Hiroaki Yuasa; Yuko Shirahama; Hiroshi Nakashima; Seiko Shimizu; Toshihide Higashino; Yusuke Kawamura; Hiraku Ogata; Makoto Kawaguchi; Yasuyuki Ohkawa; Inaho Danjoh; Atsumi Tokumasu; Keiko Ooyama; Toshimitsu Ito; Takaaki Kondo; Kenji Wakai; Blanka Stiburkova; Karel Pavelka; Lisa K Stamp; Nicola Dalbeth; Yutaka Sakurai; Hiroshi Suzuki; Makoto Hosoyamada; Shin Fujimori; Takashi Yokoo; Tatsuo Hosoya; Ituro Inoue; Atsushi Takahashi; Michiaki Kubo; Hiroshi Ooyama; Toru Shimizu; Kimiyoshi Ichida; Nariyoshi Shinomiya; Tony R Merriman; Hirotaka Matsuo
Journal:  Ann Rheum Dis       Date:  2016-11-29       Impact factor: 19.103

10.  Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population.

Authors:  Yun Sung Kim; Yunsuek Kim; Geon Park; Seong-Kyu Kim; Jung-Yoon Choe; Byung Lae Park; Hyun Sook Kim
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.